ZEROC, the new RTP Automatic Verification System, nominated for the INTERPHEX Exhibitor Award. Join us at Booth #1027 at Javits Center, New York.
Tema Sinergie is set to launch ZEROC, its latest RTP Automatic Verification System, at INTERPHEX 2025. Designed to test the integrity of Rapid Transfer Ports (RTPs) installed on isolators or RABS (Alpha part) and their containers (Beta part), ZEROC introduces a brand-new level of safety and efficiency to pharmaceutical manufacturing.
ZEROC is designed to support pharmaceutical companies in managing their Contamination Control Strategy (CCS). It’s a breakthrough in a market that is increasingly focused on addressing the critical risks associated with RTP devices while lacking effective tools to address these challenges.
Compatibility with Alpha and Beta Ports
ZEROC is designed to offer maximum system compatibility. Each unit is equipped with a specific format part that can be customized for the system to be tested, making the device virtually compatible with all transfer ports available on the market. This feature, inherited from AGLTS, provides an additional significant advantage.
By employing two testing units—one dedicated to RTPs installed on isolators and RABS (Alpha part) and the other to the corresponding containers (Beta part)—it becomes possible to monitor the entire transfer system.
Combining performance, versatility, reliability, and software compliance, ZEROC positions itself as the simplest, fastest, and most reliable solution for addressing a concern that has challenged every single aseptic process until now.
Tema Sinergie: Integrated Solutions for the Pharmaceutical Industry of Tomorrow
Professionalism, proactivity, and passion have distinguished Tema Sinergie since 1985. In recent years, the company has experienced extraordinary growth, establishing itself internationally. Tema Sinergie has significantly expanded its market presence, strengthened its team, and invested in the expansion of its production facilities.
By the way, Tema Sinergie has recently opened two branch offices in the USA and Canada in order to promptly respond to the increasing demand in the pharmaceutical and biotech market.
Discover more about Tema Sinergie Pharma & ATMP
Today, Tema Sinergie is a technological benchmark for customized barrier systems designed for the global pharmaceutical market.
Main applications offered by Tema Sinergie to the global market:
- ATMP and cell culture manipulation
- Aseptic processes and sterility testing
- HPAPI handling and containment
- Product transfer in controlled environments
- Glove integrity testing on isolators and RABS
Our leadership in isolation technology is based on decades of expertise, beginning with pioneering shielded isolators for injectable radiopharmaceuticals.
Cutting-Edge Technology, Tailored to Your Needs
Tema Sinergie develops solutions with a strong focus on the specific process, prioritizing user comfort in daily operations. From the very initial pre-sales stages, our technical sales team collaborates closely with the customer, providing dedicated engineering consultancy and defining the broad and key specifications of the application.
Discover more about Tema Sinergie technology and Solutions
The design of our isolators is constantly being enhanced thanks to ongoing dialogue with our customers. Rigorous, continuous, and calculated research into high-quality materials and components ensures these solutions offer a high level of quality and safety. These barrier systems are designed for global installation, manufactured in strict accordance with regulations set forth by the U.S. Food and Drug Administration (FDA) and equivalent bodies in Europe, the Middle East, and Africa (EMEA). Moreover, Tema Sinergie prioritizes and adheres to environmental protection as defined by the Control of Substances Hazardous to Health (COSHH) and the Occupational Safety and Health Act (OSHA).
